ArticleRheumatology and therapy2021

Inflammatory Markers are Quickly Improved by Tocilizumab in Early Polymyalgia Rheumatica and Might Predict Early Response to Interleukin-6 Blockade.

Guillermo Carvajal Alegria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.